Replies to post #31962 on Ocata Therapeutics Inc fka OCAT

[fordwill1953]

<<"If we see no safety issues, and are able to detect some engraftment of our cells to the photoreceptor / Bruch's membrane, we will obviously be dealing from a much stronger valuation and negotiating position. It is quite possible that within about 12 weeks of commencement of the trials, we may have a pretty interesting set of data to evaluate and discuss, covering an early look at a total of 6 patients between the two trials.">

STRONGER VALUATION...

Now that is a very interesting idea and makes me go hmmmmmmmmm.